Director Mark Kahrer buys 20,000 DNP (NYSE: DNP) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
DNP Select Income Fund director Mark G. Kahrer bought 20,000 shares of common stock in an open-market transaction at $10.21 per share on February 11, 2026. Following this purchase, he directly owns 23,000 DNP shares. The transaction was reported as a routine Form 4 insider purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares ($204,200)
Net Buy
1 txn
Insider
Kahrer Mark G.
Role
Director
Bought
20,000 shs ($204K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock | 20,000 | $10.21 | $204K |
Holdings After Transaction:
Common stock — 23,000 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did DNP (DNP) report for director Mark G. Kahrer?
DNP reported that director Mark G. Kahrer bought 20,000 common shares in an open-market transaction. He paid $10.21 per share and now directly owns 23,000 DNP shares, according to the Form 4 insider trading report.
Was the recent DNP (DNP) insider trade a purchase or a sale?
The recent DNP insider trade by director Mark G. Kahrer was a purchase. He acquired 20,000 common shares in an open-market transaction at $10.21 per share, increasing his direct holdings to 23,000 shares of DNP stock.
What does the Form 4 filing reveal about DNP (DNP) insider ownership changes?
The Form 4 filing shows an increase in insider ownership by director Mark G. Kahrer. He purchased 20,000 DNP common shares at $10.21 each, bringing his direct holdings to 23,000 shares following the reported open-market transaction.